RevenueLTMDec '24Dec '23Dec '22Dec '21Dec '20Dec '19Dec '18Dec '17Dec '16Dec '15Dec '14Dec '13Dec '12

Primary Care Revenue

27,793

30,135

30,799

Specialty Care Revenue

17,214

16,652

14,988

Oncology Revenue

16,462

15,612

12,450

Global Pharmaceuticals Business (Biopharma) Revenue

61,469

62,400

58,237

Business Innovation (Pfizer CentreOne) Revenue

1,255

1,146

1,272

Other Revenue

61

81

44

Total Revenue

62,785

63,627

59,553

Revenue by GeographyLTMDec '24Dec '23Dec '22Dec '21Dec '20Dec '19Dec '18Dec '17Dec '16Dec '15Dec '14Dec '13Dec '12

United States Revenue

37,180

38,691

28,145

Developed Markets Revenue

16,550

16,057

20,910

Emerging Markets Revenue (Post-FY2023 Reporting)

9,055

8,879

10,498

Other Revenue by Geography

—

—

—

Total Revenue by Geography

62,785

63,627

59,553

Revenue by GeographyLTMDec '24Dec '23Dec '22Dec '21Dec '20Dec '19Dec '18Dec '17Dec '16Dec '15Dec '14Dec '13Dec '12

United States Revenue

37,180

38,691

28,145

Developed Europe Revenue

—

—

11,650

Developed Rest of World Revenue

—

—

7,761

Emerging Markets Revenue

—

—

11,996

International Revenue

25,605

24,936

31,408

Other Revenue by Geography

—

—

—

Total Revenue by Geography

62,785

63,627

59,553

EBTLTMDec '24Dec '23Dec '22Dec '21Dec '20Dec '19Dec '18Dec '17Dec '16Dec '15Dec '14Dec '13Dec '12

Global Pharmaceuticals Business (Biopharma) Earnings

28,804

28,139

15,923

Other Business Activities Earnings

-8,166

-7,382

-4,342

Other EBT

-11,485

-12,734

-10,524

Total EBT

9,153

8,023

1,057

Key Performance IndicatorsLTMDec '24Dec '23Dec '22Dec '21Dec '20Dec '19Dec '18Dec '17Dec '16Dec '15Dec '14Dec '13Dec '12

Comirnaty Direct Sales and Alliance Revenue

5,480

5,353

11,220

Eliquis Alliance Revenue and Direct Sales

7,773

7,366

6,747

Prevnar Revenue

—

—

6,440

Paxlovid Revenue

2,870

5,716

1,279

Prevnar Family Revenue

6,343

6,411

6,501

Nurtec ODT/Vydura Revenue

1,411

1,263

928

Abrysvo Revenue

751

755

890

Vyndaqel Family Revenue

6,236

5,451

3,321

Xeljanz Revenue

1,113

1,168

1,703

Ibrance Revenue

4,178

4,367

4,753

Consumer Healthcare Revenue

—

—

—

Vaccines Revenue

—

—

—

Internal Medicine Revenue

—

—

—

Hospital Revenue

—

—

—

Inflammation & Immunology Revenue

—

—

—

Rare Disease Revenue

—

—

—